Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of DRW8.F
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Drägerwerk AG & Co. KGaA stock upgraded to Strong Buy Candidate.
(Updated on May 14, 2024)

Buy candidate since May 13, 2024 Gain 0.22% PDF

The Drägerwerk AG & Co. KGaA stock price gained 0.222% on the last trading day (Tuesday, 14th May 2024), rising from 45.00€ to 45.10€. During the last trading day the stock fluctuated 0.670% from a day low at 44.80€ to a day high of 45.10€. The price has risen in 7 of the last 10 days and is up by 4.88% over the past 2 weeks. Volume fell on the last day by -2 thousand shares and in total, 526 shares were bought and sold for approximately 23.72€ thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7.19% during the next 3 months and, with a 90% probability hold a price between 45.86€ and 50.66€ at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

DRW8.F Signals & Forecast

The Drägerwerk AG & Co. KGaA stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at 44.80€ and 44.69€. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, April 26, 2024, and so far it has risen 6.87%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. The stock had a Golden Star Signal on Thursday, October 05, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star 12 Months

The stock had a Golden Star Signal on Thursday, October 05, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Drägerwerk AG & Co. KGaA stock

Drägerwerk AG & Co. KGaA finds support from accumulated volume at 45.00€ and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved 0.300€ between high and low, or 0.670%. For the last week the stock has had daily average volatility of 2.03%

Our recommended stop-loss: 43.26€ (-4.08%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 11 days ago.)

Trading Expectations (DRW8.F) For The Upcoming Trading Day Of Wednesday 15th

For the upcoming trading day on Wednesday, 15th we expect Drägerwerk AG & Co. KGaA to open at 45.00€, and during the day (based on 14 day Average True Range), to move between 44.16€ and 46.04€, which gives a possible trading interval of +/-0.94€ (+/-2.09%) up or down from last closing price. If Drägerwerk AG & Co. KGaA takes out the full calculated possible swing range there will be an estimated 4.19% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at 45.00€ (0.22%) than the resistance at 45.30€ (0.44%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Drägerwerk AG & Co. KGaA stock A Buy?

Drägerwerk AG & Co. KGaA holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 6.096 Strong Buy Candidate Upgraded

Predicted Opening Price for Drägerwerk AG & Co. KGaA of Wednesday, May 15, 2024

Fair opening price May 15, 2024 Current price
45.00€ ( 0.222%) 45.10€

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for DRW8.F

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 45.30 0.443 %
R2 45.19 0.189 %
R1 45.11 0.0324 %
Current price: 45.10
Support S1 44.89 -0.476 %
S2 44.81 -0.633 %
S3 44.70 -0.89 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 45.90 1.77 %
R2 45.50 0.89 %
R1 45.30 0.443 %
Current price 45.10
Support S1 45.00 -0.222%
S2 44.00 -2.44%
S3 42.90 -4.88%

DRW8 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 09, 2024 May 09, 2024 May 13, 2024 1.74€ 0%
2 May 08, 2023 May 08, 2023 May 08, 2023 0.130€ 0%
3 May 09, 2022 May 09, 2022 May 09, 2022 0.130€ 0%
4 May 10, 2021 May 10, 2021 May 10, 2021 0.130€ 0%
5 Oct 01, 2020 Oct 01, 2020 Oct 01, 2020 0.130€ 0%

FAQ

What is the symbol for Drägerwerk AG & Co. KGaA Stock and on which exchange is it traded?
The symbol for Drägerwerk AG & Co. KGaA is DRW8.F and it is traded on the FRA (Frankfurt Stock Exchange).

Should I buy or sell Drägerwerk AG & Co. KGaA Stock?
Drägerwerk AG & Co. KGaA holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

How to buy Drägerwerk AG & Co. KGaA Stock?
Drägerwerk AG & Co. KGaA Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Drägerwerk AG & Co. KGaA Stock.

What's the current price of Drägerwerk AG & Co. KGaA Stock?
As of the end of day on the May 14, 2024, the price of an Drägerwerk AG & Co. KGaA (DRW8.F) share was 45.10€.

What is the 52-week high and low for Drägerwerk AG & Co. KGaA Stock?
The 52-week high for Drägerwerk AG & Co. KGaA Stock is 47.50€ and the 52-week low is 37.20€.

What is the market capitalization of Drägerwerk AG & Co. KGaA Stock?
As of the May 14, 2024, the market capitalization of Drägerwerk AG & Co. KGaA is 896.239M.

When is the next earnings date for Drägerwerk AG & Co. KGaA?
The upcoming earnings date for Drägerwerk AG & Co. KGaA is Jul 25, 2024.
Click to get the best stock tips daily for free!

About Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... DRW8.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT